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1. Introduction
Osteoarthrosis (OA) is the 
most common form of the artic-
ular pathology, which is based 
on degeneration of the articu-
lar cartilage with subsequent or 
simultaneous changes in bone 
articular surfaces and underlying 
bone, development of margin-
al osteophytes, deformation of 
the joint [1–3]. Women are more 
susceptible to the disease at the 
age of 50–60, after 60 years old 
the disease occurs in almost all 
people [2–4].
Female gender, advanced age, 
endocrine and metabolic disor-
ders, overweight, muscle weak-
ness, joint trauma, overload, sur- 
gery and inflammatory joint dis-
eases are the main risk factors for 
OA development [5, 6].
The combination of the met-
abolic syndrome (MS) and os-
teoarthrosis creates conditions 
for congestion of functioning of 
axial joints, which is one of the 
main causes of premature dis-
ability and invalidization of the 
population [4, 7].
In the treatment of OA, the 
main task is to slow down the 
progression of the disease, pre-
serve the structural and func-
tional integrity of the cartilage 
and, thus, to improve the quality 
of life and prevent disability. And 
the tasks of symptomatic thera- 
py – reduction of pain and in-
flammation and frequency of ex-
acerbations are also solved [8, 9].
According to the classifi-
cation of drugs for the treat-
ment of OA recommended by the WHO committee and 
supported by OARSI, there are symptomatic drugs of rap-
id action, slow-acting symptomatic drugs (SYSADOA) 
and drugs that modify the course of the disease [9, 10].
Slow-acting symptomatic drugs such as chondroitin sul-
fate, glucosamine sulfate, unsaponifiable extracts of soybean 
and avocado (Piascladin 300), diacerein and hyaluronic acid 
have a positive effect on pain and dysfunction after a few 
months, and this result persists for some time after dis-
continuation of treatment. Treatment with these drugs is 
accompanied by a decrease in the need for analgesics and 
NSAIDs [9, 10].
The aim of the study was to determine the effect of the 
drug from soybean and avocado on the course of osteoar-
throsis of knee joints with concomitant metabolic syndrome 
in women in the menopausal period.
2. Material and Methods
The study has been conducted in 2016 for 3 months at the 
rheumatology department on the basis of the University Clinic 
of Odessa National Medical University. 
The study included 60 wom-
en aged 50 to 75 (mean age 
62.17±7.67), with a reliable diag-
nosis of knee osteoarthrosis ac- 
cording to the criteria of the 
American College of Rheumatol-
ogy (ACR), having the I–II ra- 
diological stage according to 
Kellgren-Lawrence, the meno-
pausal period (the average duration 
of menopause is 8.5±0.43 years) 
and with the metabolic syndrome 
(body mass index more than 
25 kg/m², SBP/DBP – 149+1.5/87+ 
+0.9, mm, OT 95 4±0.94 cm, glu-
cose – 5.9±0.03 mmol/l, insulin – 
14.6+0.07 μED/ml). All patients 
were divided into 2 groups of 
30 people according to the treat-
ment. Group I patients under-
went therapy with NSAIDs in the 
form of the drug movalis 15 mg 
per day as well as a preparation 
of soybean and avocado (Pias-
kledin-300) 1 tablet per day for 
3 months. Patients of group II 
were treated with NSAIDs and a 
chondroprotector in the form of 
an arthron-complex preparation 
for 3 months. Before and after 
treatment, all patients underwent 
X-ray examination of knee joints, 
study of acute phase indices (ESR, 
CRP, seromucoids, fibrinogen) to 
assess the severity of inflamma-
tion. All patients underwent pain 
syndrome assessment by visual 
analogue scale (VAS), WOMAC 
index quality of life assessment 
and joint mobility study with the 
help of a goniometer to determine 
active and passive joint mobility.
3. Results
After the therapy with the administration of soybean and 
avocado drugs for 3 months in Group I, there was a significant 
improvement in the clinical course of osteoarthrosis of knee 
joints more pronounced than in Group II, where NSAIDs and 
chondroprotectors were prescribed. The intensity of pain ac-
cording to the VAS significantly decreased by 26.6 % (Table 1) 
and the quality of life improved by 29.2 % in all indices of the 
WOMAC index (Table 2).
Table 1
Dynamics of the intensity of the pain syndrome before and  
after treatment in both groups
Index of the pain 
syndrome









Pain intensity by VAS 5.97+0.05 4.38+0.04* 5.96+0.06  5.63+0.03*,**
Note: * – the reliability of differences between the indices before and after 
treatment p <0.05; ** – reliability of differences in the indices after treat-
ment in І and II groups p<0.05
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Abstract: The most common articular pathology is osteo-
arthrosis of the knee joints. More than 10 % of the world's 
population suffers from this disease. The development of 
osteoarthrosis (OA) is also affected by metabolic syndrome 
(MS), which is characterized by abdominal obesity, dys-
lipidemia, arterial hypertension and disturbance of carbo-
hydrate metabolism. The combination of MS and osteoar-
throsis creates conditions of overload for the functioning of 
axial joints, which is one of the main causes of premature 
disability and invalidization of the population.
Treatment of OA of the knee joints in women in the men-
opausal period with concomitant metabolic syndrome pre-
sents great difficulties. To achieve a stable result of treatment, 
therapy with chondroprotectors and nonsteroidal anti-in-
flammatory drugs (NSAIDs) is used. Treatment was carried 
out in 60 women in the menopausal period with MS, suffer-
ing from OA of knee joints. In the group of women in the 
menopausal period with OA of knee joints and MS who took 
therapy with the inclusion of the soybean and avocado drug 
alongside with NSAIDs, a significant effect was obtained 
with regard to arresting the pain syndrome, improving the 
quality of life, reducing the degree of inflammation as well as 
increased joint mobility compared with the group of patients, 
who took only chondroprotectors and NSAIDs.
Keywords: osteoarthriosis, knee joints, metabolic syndrome, 
women, menopausal period, soybean and avocado drug.
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According to the laboratory and clinical data, the severity of 
inflammatory reactions after therapy with the use of the drug 
from soybean and avocado in group I and the standard drug 
therapy in group II significantly decreased (Table 3). The mobil-
ity of knee joints was assessed using a goniometer in patients 
of different groups before and after treatment (Fig. 1).
Table 2








Before treatment After treatment % reduction Before treatment After treatment
Pain intensity 154.17±12.3 105.53±6.9* 31.5 154.31±13.3 116.33±6.9*, ** 24.6
Stiffness 67.31±4.9 42.07±3.1* 37.5 68.27±6.1 53,22±3.1*, ** 22
Functional  
insufficiency 458.36±35.3 390.81±27.5* 14.7 457.73±45.5 398.25±27.3*, ** 12.9
WOMAC total 657,37±55.4 465.42±38.3* 29.2 652.57±67.3 585.17±29.4*, ** 10.3
Note: * – the reliability of differences between the indices before and after treatment p<0.05; ** – reliability of differences in the indices after treatment 
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a                                                                                                             b 
Fig. 1. Assessment of joint mobility with the help of a goniometer before and after treatment in the groups under study:  
a – І group; b – ІI group
Table 3
Dynamics of inflammatory indices in women in the menopausal period with OA of knee joints and MS under the influence of 
treatment in both groups
Index
I group  
n=30 М±m
II group  
n=30 М±m
Before treatment After treatment Before treatment After treatment
CRP, mg/l 9.1±0.01 5.4±0.02* 9.2±0.01 6.3±0.02*, **
Fibrinogen, g/l 5.12±0.03 3.73±0.03* 5.23±0.05 4.24±0.05*, **
Seromucoid, units. 0.320±0.003 0.170±0.004* 0.320±0.002 0.260±0.002*, **
ESR, mm/hr 18±1.02 9±1.01* 18±1.06 14±1.03*, **
IL-1A, pg/l 7.4±0.03 4.8±0.02* 7.3±0.02 5.9±0.04*, **
Note: * – the reliability of differences between the indices before and after treatment p<0.05; ** – reliability of differences in the indices after treatment 
in І and II groups p<0.05
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abolic syndrome, the intensity of the pain syndrome according 
to VAS decreased by 26.6 % (p<0.05) and the WOMAC index 
decreased by 29.2 % (p<0.05) in all positions: the pain severity 
decreased by 31.5 %, stiffness by 37.5 %, the functional insuf-
ficiency by 14.7 % compared with the group of patients who 
received standard medication.
Treatment with the administration of the drug from soy-
beans and avocado increases the mobility of the knee joints by 
25 % (p<0.05) and decreases inflammation in women in the 
menopausal period suffering from OA of the knee joints by 30 % 
compared with group II who received the standard medication.
Proceeding from the data obtained of therapy with inclu-
sion of the drug from soybeans and avocado, it is the most 
effective and expedient in the given category of patients.
In further studies, the results obtained are planned to de-
velop as to the impact on the production of pro-inflammatory 
cytokines (IL-6), metabolism of the articular cartilage and the 
ability to inhibit the progression of the articular cartilage.
5. Discussion
The existing protocols should use high-speed symptom-mod-
ifying drugs for the treatment of osteoarthritis of knee joints, 
which, while giving an analgesic effect, affects the gastrointestinal 
tract, cardiovascular system and kidneys. Therefore, the use of 
the drug from soybeans and avocados allows to achieve a more 
pronounced effect without affecting any organs and systems of 
the human body.
Advantages of the results obtained are non-toxicity of this 
drug, its positive effect on metabolism of the articular carti-
lage and inhibition of intreleukin-1 (IL-1A). The disadvantage 
of the drug from soybean and avocado is the possibility of 
side effects, such as diarrhea, but this was not observed in 
the study.
After the treatment with the inclusion of chondropro-
tectors in the form of soybean and avocado Piaskledin 300 
alongside with NSAIDs in women in the menopausal period 
suffering from OA of knee joints in combination with the met-
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